Display options
Share it on

Cytotechnology. 1999 Nov;31(3):233-42. doi: 10.1023/A:1008030730814.

Enhanced CEA production associated with aspirin in a culture of CW-2 cells on some polymeric films.

Cytotechnology

A Higuchi, S Uchiyama, M Demura, T Asakura, C S Cho, T Akaike, H Takarada, M Hara

Affiliations

  1. Department of Industrial Chemistry, Seikei University, Musashino, 180-8633, Japan.

PMID: 19003147 PMCID: PMC3449545 DOI: 10.1023/A:1008030730814

Abstract

Human colorectal adenocarcinoma tumor (CW2) cells were cultivated in RPMI 1640 media containing 0-7.5 mM aspirin and 10% fetal bovine serum for the production of carcinoembryonic antigen (CEA). By adding aspirin to the media, the production of CEA per cell increased by up to one hundred fold compared to cultivation in normal media containing no aspirin, even though the total cell concentration decreased with the increase in aspirin in the media. The production of CEA was also investigated for CW2 cells cultured on silk fibroin, poly(gamma-benzyl-L-glutamate) and poly(gamma-benzyl-L-glutamate)/poly(ethylene oxide) diblock copolymer films prepared by the Langmuir-Blodgett and casting methods. The highest production of CEA per cell was observed for the CW2 cells on poly(gamma-benzyl-L-glutamate) and its diblock copolymer films prepared by the Langmuir-Blodgett method in the medium containing 5 mM aspirin after 168 hr of inoculation. This originates from the fact that the cell density on the films in the medium containing 5 mM aspirin was the lowest under these conditions. It is suggested that CW2 cells produce CEA more effectively when the cell growth is suppressed by addition of toxic chemicals such as aspirin or by culture on unfavorable films for cell growth.

References

  1. Biotechnol Prog. 1990 May-Jun;6(3):231-6 - PubMed
  2. J Biomed Mater Res. 1996 Nov;32(3):425-32 - PubMed
  3. J Biotechnol. 1990 Oct;16(1-2):67-85 - PubMed
  4. Cancer Res. 1965 May;25:517-25 - PubMed
  5. Biochemistry. 1976 Dec 14;15(25):5501-6 - PubMed
  6. Cytotechnology. 1993;13(3):221-6 - PubMed
  7. Cytotechnology. 1994;16(1):1-15 - PubMed
  8. Cytotechnology. 1990 Mar;3(2):189-97 - PubMed
  9. Cytotechnology. 1997 Jan;23(1-3):55-9 - PubMed
  10. Cytotechnology. 1997 May;24(1):47-54 - PubMed
  11. In Vitro. 1980 Feb;16(2):113-8 - PubMed
  12. Cytotechnology. 1993;13(3):161-73 - PubMed
  13. Cytotechnology. 1991 Mar;5(3):255-63 - PubMed
  14. Cytotechnology. 1994;15(1-3):57-64 - PubMed
  15. J Natl Cancer Inst. 1979 Oct;63(4):893-902 - PubMed
  16. Toxicol In Vitro. 1993 Jul;7(4):517-21 - PubMed
  17. Cytotechnology. 1997 Jul;24(2):177-82 - PubMed
  18. Cytotechnology. 1997 Jan;23(1-3):5-12 - PubMed
  19. J Natl Cancer Inst. 1978 Feb;60(2):303-6 - PubMed

Publication Types